Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial.

PLoS One · 2023 · PMC10019690 · PMID 36928877

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

The earlier recovery in the AYUSH plus group was also observed for ‘time to clinical recovery from the onset of symptom’ and this was marginally significant as compared to SOC ( Table 2 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.